mictonorm uno 30 mg hartkapseln mit veränderter wirkstofffreisetzung
mictonorm uno 45 mg hartkapseln mit veränderter wirkstofffreisetzung
detrunorm xl capsules
pharmafrica (pty) ltd - capsules - see ingredients - each capsule contains propiverine hydrochloride 30,0 mg
midolam 1 mgml
rafa laboratories ltd - midazolam - solution for injection - midazolam 1 mg/ml - midazolam - midazolam - midazolam is a short-acting sleep-inducing drug that is indicated:in adults• conscious sedation before and during diagnostic or therapeutic procedures with or without local anaesthesia• anaesthesia- premedication before induction of anaesthesia- induction of anaesthesia- as a sedative component in combined anaesthesia• sedation in intensive care unitsin children• conscious sedation before and during diagnostic or therapeutic procedures with or without local anaesthesia• anaesthesia- premedication before induction of anaesthesia• sedation in intensive care units
midolam 5 mgml
rafa laboratories ltd - midazolam - solution for injection - midazolam 5 mg/ml - midazolam - midazolam - midazolam is a short-acting sleep-inducing drug that is indicated:in adults• conscious sedation before and during diagnostic or therapeutic procedures with or without local anaesthesia• anaesthesia- premedication before induction of anaesthesia- induction of anaesthesia- as a sedative component in combined anaesthesia• sedation in intensive care unitsin children• conscious sedation before and during diagnostic or therapeutic procedures with or without local anaesthesia• anaesthesia- premedication before induction of anaesthesia• sedation in intensive care units
dormicum injection 5 mg5 ml
dksh singapore pte. ltd. - midazolam - injection - 5 mg/5 ml - midazolam 1 mg/ml
dormicum tablet 7.5 mg
roche singapore pte. ltd. - midazolam maleate 10.2mg eqv. to midazolam - tablet, film coated - 7.5mg
dormicum injection 15 mg3 ml
dksh singapore pte. ltd. - midazolam - injection - 15 mg/3 ml - midazolam 5 mg/ml
dormicum tablet 15 mg
dksh singapore pte. ltd. - midazolam maleate 20.40 mg eqv. to midazolam - tablet, film coated - 15 mg - midazolam maleate 20.40 mg eqv. to midazolam 15 mg
lojuxta
amryt pharmaceuticals dac - lomitapide - hypercholesterolemia - lipid modifying agents - lojuxta is indicated as an adjunct to a low‑fat diet and other lipid‑lowering medicinal products with or without low-density-lipoprotein (ldl) apheresis in adult patients with homozygous familial hypercholesterolaemia (hofh). genetic confirmation of hofh should be obtained whenever possible. other forms of primary hyperlipoproteinaemia and secondary causes of hypercholesterolaemia (e.g. nephrotic syndrome, hypothyroidism) must be excluded.,